Show Summary Details
Page of

Antiretroviral Therapy 

Antiretroviral Therapy
Chapter:
Antiretroviral Therapy
Author(s):

John G. Bartlett

, Robert R. Redfield

, and Paul A. Pham

DOI:
10.1093/med/9780190924775.003.0004
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 July 2022

Abstract: This chapter is about antiretroviral therapy (ART). It includes the goals of antiretroviral therapy (according to the 2018 Department of Health and Human Services [DHHH] guidelines), and it covers recommendations for antiretroviral therapy, special co-factor considerations, and what antiretroviral regimen to start. The chapter includes a detailed discussion on the selection of the initial third ART drug, individualized selection of the initial regimen, initiating ART in a patient with HIV-associated complications, treatment of HIV-2 infection, factors that influence the probability of prolonged viral suppression and regimen tolerability, the rapidity of virologic response, clinical failure, treatment strategies in selected situations, and treatment strategies in the setting of immunologic failure. The chapter concludes with a summary of pivotal antiretroviral trials.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.